These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26912430)

  • 21. Lower Availability of Mitochondrial Complex I in Anterior Cingulate Cortex in Autism: A Positron Emission Tomography Study.
    Kato Y; Yokokura M; Iwabuchi T; Murayama C; Harada T; Goto T; Tamayama T; Kameno Y; Wakuda T; Kuwabara H; Benner S; Senju A; Tsukada H; Nishizawa S; Ouchi Y; Yamasue H
    Am J Psychiatry; 2023 Apr; 180(4):277-284. PubMed ID: 36069020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
    Tabbal SD; Mink JW; Antenor JA; Carl JL; Moerlein SM; Perlmutter JS
    Neuroscience; 2006 Sep; 141(3):1281-7. PubMed ID: 16766129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine congeners as PET imaging probes for dopamine terminals.
    Brownell AL; Elmaleh DR; Meltzer PC; Shoup TM; Brownell GL; Fischman AJ; Madras BK
    J Nucl Med; 1996 Jul; 37(7):1186-92. PubMed ID: 8965196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Terada T; Obi T; Bunai T; Matsudaira T; Yoshikawa E; Ando I; Futatsubashi M; Tsukada H; Ouchi Y
    Neurology; 2020 Apr; 94(15):e1592-e1604. PubMed ID: 32139504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
    Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ
    Synapse; 1988; 2(5):469-73. PubMed ID: 3263709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate receptor avidity is reduced in non-motor impaired MPTP-lesioned rhesus monkeys.
    Cohen RM; Carson RE; Aigner TG; Doudet DJ
    Brain Res; 1998 Sep; 806(2):292-6. PubMed ID: 9739155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualizing mitochondrial (dys)function using positron emission tomography imaging.
    Srivastava A; Prasad PV
    Kidney Int; 2020 Jul; 98(1):51-53. PubMed ID: 32571489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR; Huang SC; Melega WP; Yu DC; Hoffman JM; Schneider JS; Satyamurthy N; Mazziotta JC; Phelps ME
    J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.
    Melega WP; Hoffman JM; Schneider JS; Phelps ME; Barrio JR
    Brain Res; 1991 Mar; 543(2):271-6. PubMed ID: 1905578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCPP compounds, PET probes for early therapeutic evaluations, specifically bind to mitochondrial complex I.
    Kazami S; Nishiyama S; Kimura Y; Itoh H; Tsukada H
    Mitochondrion; 2019 May; 46():97-102. PubMed ID: 29563046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acetaminophen on mitochondrial complex I activity in the rat liver and kidney: a PET study with
    Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
    EJNMMI Res; 2016 Dec; 6(1):82. PubMed ID: 27873239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.
    Saiki H; Hayashi T; Takahashi R; Takahashi J
    J Neurosci Methods; 2010 Jul; 190(2):198-204. PubMed ID: 20488205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs.
    Lillethorup TP; Noer O; Alstrup AKO; Real CC; Stokholm K; Thomsen MB; Zaer H; Orlowski D; Mikkelsen TW; Glud AN; Nielsen EHT; Schacht AC; Winterdahl M; Brooks DJ; Sørensen JCH; Landau AM
    Neurotoxicology; 2022 Jul; 91():166-176. PubMed ID: 35569565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain:
    Mansur A; Rabiner EA; Comley RA; Lewis Y; Middleton LT; Huiban M; Passchier J; Tsukada H; Gunn RN;
    J Nucl Med; 2020 Jan; 61(1):96-103. PubMed ID: 31324712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.